Morgan Stanley Sees Multiple Challenges Ahead for The Clorox Co.

In a report published Wednesday, Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and $85.00 price target on The Clorox Co. (NYSE: CLX ). In the report, Morgan Stanley noted, “We remain UW [on] CLX given we believe weak US consumer spending, heightened competition with incremental promotion, and Venezuela/Argentina